Heart disease biotech Tenaya Therapeutics files for a $100 million IPO

https://www.renaissancecapital.com/IPO-Center/News/83887/Heart-disease-biotech-Tenaya-Therapeutics-files-for-a-$100-million-IPO
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.